Overall, treatment had no significant acute effect on hemoglobin, hematocrit, plasma creatinine, sodium, potassium, and urate levels, although there was a clear trend toward an increase in hemoglobin and creatinine after the first dose of empagliflozin.
← all excerpts
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial.
1
—
—